TNFRSF13C Polyclonal Antibody
| Code | Size | Price |
|---|
| E-AB-16646-20uL | 20uL | £125.00 |
Quantity:
| E-AB-16646-60uL | 60uL | £172.00 |
Quantity:
| E-AB-16646-120uL | 120uL | £237.00 |
Quantity:
| E-AB-16646-200uL | 200uL | £344.00 |
Quantity:
Prices exclude any Taxes / VAT
Overview
Host Type: Rabbit
Antibody Isotype: IgG
Antibody Clonality: Polyclonal
Regulatory Status: RUO
Target Species:
- Human
- Mouse
Applications:
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Immunohistochemistry (IHC)
Shipping:
Ice packs
Storage:
-20°C
Further Information
Abbreviation:
TNFRSF13C
Background:
B cell-activating factor (BAFF) enhances B-cell survival in vitro and is a regulator of the peripheral B-cell population. Overexpression of Baff in mice results in mature B-cell hyperplasia and symptoms of systemic lupus erythematosus (SLE). Also, some SLE patients have increased levels of BAFF in serum. Therefore, it has been proposed that abnormally high levels of BAFF may contribute to the pathogenesis of autoimmune diseases by enhancing the survival of autoreactive B cells. The protein encoded by this gene is a receptor for BAFF and is a type III transmembrane protein containing a single extracellular cysteine-rich domain. It is thought that this receptor is the principal receptor required for BAFF-mediated mature B-cell survival.
Buffer:
PBS with 0.05% sodium azide and 50% glycerol, PH7.4
Concentration:
0.7 mg/mL
Conjugation:
Unconjugated
Dilution:
IHC 1:50-1:200
Immunogen:
Synthetic peptide of human TNFRSF13C
Purification method:
Affinity purification
Target Synonym:
B cell activating factor receptor;B-cell-activating factor receptor;BAFF R;BAFF receptor;BAFF-R;BAFFR;BLyS receptor 3;BlySR3;BR 3;BR3;BROMIX;CD 268;CD268;CD268 antigen;CVID4;MGC138235;OTTHUMP00000028746;Prolixin;TNFRSF 13C;Tnfrsf13c;TR13C;Tumor necrosis factor receptor subunit member 13C;Tumor necrosis factor receptor superfamily member 13C
UNIProt ID:
Q96RJ3